U.S. National Institutes of Health
American practices of paying research subjects characterized
Published in Biotech Law Weekly, August 5th, 2005
"Despite controversy about paying research subjects, little is known about actual practices in the U.S., including what type of studies offer payment, to what type of subjects, and how amounts are determined," scientists in the United States explained.
In a study conducted by C. Grady and colleagues at the National Institutes of Health, the "protocols and consent forms of 467 studies offering payment to research subjects approved by 11 IRBs across the U.S. were reviewed to analyze how they describe and justify payment to subjects."
"Money was offered in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2005-08-05)
More Articles from Biotech Law Weekly
- Azee, Inc.
Genomics company completes agreement for small molecule technology - Bavarian Nordic A/S
U.S. patent granted for modified virus ankara - Blue Cross and Blue Shield of Minnesota
Seven healthcare benefit plans form alliance to offer regional Medicare products - Braintree Laboratories, Inc.
Company increases presence in the pediatric market with Axid acquisition - Cardiomedics, Inc.
Company applies for Medicare coverage of heart failure treatment - Collaborations
Strategic alliance formed to help Medicare beneficiaries with drug plans - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
